Home Applications 201380 Application 201380
Type ANDA
Sponsor MACLEODS PHARMS LTD Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 AMLODIPINE BESYLATE AMLODIPINE BESYLATE TABLET;ORAL EQ 5MG BASE No No 002 AMLODIPINE BESYLATE AMLODIPINE BESYLATE TABLET;ORAL EQ 10MG BASE No No 003 AMLODIPINE BESYLATE AMLODIPINE BESYLATE TABLET;ORAL EQ 2.5MG BASE No No
Source provenance: Browse the complete Orange Book source catalog · source snapshot 45 .
Orange Book products# Current product rows page 1 of 1 · 3 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A201380-001 AMLODIPINE BESYLATE AMLODIPINE BESYLATE EQ 5MG BASE TABLET / ORAL AB 2012-04-13 A201380-002 AMLODIPINE BESYLATE AMLODIPINE BESYLATE EQ 10MG BASE TABLET / ORAL AB 2012-04-13 A201380-003 AMLODIPINE BESYLATE AMLODIPINE BESYLATE EQ 2.5MG BASE TABLET / ORAL AB 2026-02-17
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 3 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 3 · 95 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-11-14 07:37:17 2026-10 A201380-001 AMLODIPINE BESYLATE EQ 5MG BASE TABLET / ORAL AB 2012-04-13 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 A201380-002 AMLODIPINE BESYLATE EQ 10MG BASE TABLET / ORAL AB 2012-04-13 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 A201380-003 AMLODIPINE BESYLATE EQ 2.5MG BASE TABLET / ORAL AB 2026-02-17 d4dbc9d85df4…2026-10-15 13:18:30 2026-09 A201380-001 AMLODIPINE BESYLATE EQ 5MG BASE TABLET / ORAL AB 2012-04-13 c2088c7a36db…2026-10-15 13:18:30 2026-09 A201380-002 AMLODIPINE BESYLATE EQ 10MG BASE TABLET / ORAL AB 2012-04-13 c2088c7a36db…2026-10-15 13:18:30 2026-09 A201380-003 AMLODIPINE BESYLATE EQ 2.5MG BASE TABLET / ORAL AB 2026-02-17 c2088c7a36db…2026-09-14 22:38:34 2026-08 A201380-001 AMLODIPINE BESYLATE EQ 5MG BASE TABLET / ORAL AB 2012-04-13 84e616aacf4f…2026-09-14 22:38:34 2026-08 A201380-002 AMLODIPINE BESYLATE EQ 10MG BASE TABLET / ORAL AB 2012-04-13 84e616aacf4f…2026-09-14 22:38:34 2026-08 A201380-003 AMLODIPINE BESYLATE EQ 2.5MG BASE TABLET / ORAL AB 2026-02-17 84e616aacf4f…2026-08-18 06:07:40 2026-07 A201380-001 AMLODIPINE BESYLATE EQ 5MG BASE TABLET / ORAL AB 2012-04-13 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A201380-002 AMLODIPINE BESYLATE EQ 10MG BASE TABLET / ORAL AB 2012-04-13 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A201380-003 AMLODIPINE BESYLATE EQ 2.5MG BASE TABLET / ORAL AB 2026-02-17 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 A201380-001 AMLODIPINE BESYLATE EQ 5MG BASE TABLET / ORAL AB 2012-04-13 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A201380-002 AMLODIPINE BESYLATE EQ 10MG BASE TABLET / ORAL AB 2012-04-13 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A201380-001 AMLODIPINE BESYLATE EQ 5MG BASE TABLET / ORAL 2012-04-13 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A201380-002 AMLODIPINE BESYLATE EQ 10MG BASE TABLET / ORAL 2012-04-13 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A201380-001 AMLODIPINE BESYLATE EQ 5MG BASE TABLET / ORAL 2012-04-13 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A201380-002 AMLODIPINE BESYLATE EQ 10MG BASE TABLET / ORAL 2012-04-13 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A201380-001 AMLODIPINE BESYLATE EQ 5MG BASE TABLET / ORAL 2012-04-13 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A201380-002 AMLODIPINE BESYLATE EQ 10MG BASE TABLET / ORAL 2012-04-13 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A201380-001 AMLODIPINE BESYLATE EQ 5MG BASE TABLET / ORAL 2012-04-13 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A201380-002 AMLODIPINE BESYLATE EQ 10MG BASE TABLET / ORAL 2012-04-13 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A201380-001 AMLODIPINE BESYLATE EQ 5MG BASE TABLET / ORAL 2012-04-13 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A201380-002 AMLODIPINE BESYLATE EQ 10MG BASE TABLET / ORAL 2012-04-13 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A201380-001 AMLODIPINE BESYLATE EQ 5MG BASE TABLET / ORAL 2012-04-13 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A201380-002 AMLODIPINE BESYLATE EQ 10MG BASE TABLET / ORAL 2012-04-13 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A201380-001 AMLODIPINE BESYLATE EQ 5MG BASE TABLET / ORAL 2012-04-13 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A201380-002 AMLODIPINE BESYLATE EQ 10MG BASE TABLET / ORAL 2012-04-13 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A201380-001 AMLODIPINE BESYLATE EQ 5MG BASE TABLET / ORAL 2012-04-13 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A201380-002 AMLODIPINE BESYLATE EQ 10MG BASE TABLET / ORAL 2012-04-13 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A201380-001 AMLODIPINE BESYLATE EQ 5MG BASE TABLET / ORAL 2012-04-13 d06236e962d9…2024-10-29 15:01 UTC 2024-10 A201380-002 AMLODIPINE BESYLATE EQ 10MG BASE TABLET / ORAL 2012-04-13 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A201380-001 AMLODIPINE BESYLATE EQ 5MG BASE TABLET / ORAL 2012-04-13 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A201380-002 AMLODIPINE BESYLATE EQ 10MG BASE TABLET / ORAL 2012-04-13 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A201380-001 AMLODIPINE BESYLATE EQ 5MG BASE TABLET / ORAL 2012-04-13 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A201380-002 AMLODIPINE BESYLATE EQ 10MG BASE TABLET / ORAL 2012-04-13 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A201380-001 AMLODIPINE BESYLATE EQ 5MG BASE TABLET / ORAL 2012-04-13 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A201380-002 AMLODIPINE BESYLATE EQ 10MG BASE TABLET / ORAL 2012-04-13 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 A201380-001 AMLODIPINE BESYLATE EQ 5MG BASE TABLET / ORAL 2012-04-13 8072bd15b7f6…2024-05-31 18:47 UTC 2024-05 A201380-002 AMLODIPINE BESYLATE EQ 10MG BASE TABLET / ORAL 2012-04-13 8072bd15b7f6…
Observed Orange Book normalized TE history# openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application# NDC listings for this application page 1 of 1 · 2 matching rows.
NDC, Name, Nonproprietary name table NDC Name Nonproprietary name Labeler Marketing category Status 33342-015 Amlodipine Amlodipine Macleods Pharmaceuticals Limited ANDA Current 33342-016 Amlodipine Amlodipine Macleods Pharmaceuticals Limited ANDA Current